Overcoming Emmetropic Presbyopia by Optimal Keratoplasty (Opti-K)

PURPOSE: To evaluate the safety and efficacy of the VIS Optimal Keratoplasty (Opti-K) device and procedure for treating eyes with emmetropic presbyopia to achieve uncorrected near visual acuity (UNVA) improvement. SETTING: Bahamas Vision Centre, Nassau, New Providence, The Bahamas METHODS: 145 eyes of 75 patients with emmetropic presbyopia (MRSE = -0.25 to +0.75 D; mean add and standard deviation (SD) = 1.89 (0.35 D) received primary treatments (Txs) by the VIS NTK Optimal Keratoplasty (Opti-K) device; 66 and 16 eyes also received secondary and ternary Txs, respectively. Patients were treated to produce best uncorrected near visual acuity (UNVA) in both eyes using a multifocal vision protocol. Safety and efficacy measures with follow-up (f/u) extending to 24 months post-Tx were analyzed. RESULTS: Safety - There were no clinically significant adverse events or complications. Changes in intraocular pressure (IOP) and astigmatism (A) were not statistically significant (p < 0.05). Increase of central corneal thickness (CCT) was not clinically significant. Efficacy - Geometric mean (gm) (SD) binocular UNVA improvements corresponded to 4.0 (2.0) lines gained at 1day′ post-secondary Tx (p < 10-6), with gradual reduction of improvement to 1.8 (1.5) lines gained at 24m′ (p = 0.002). Gm UDVA was conserved or even improved at most f/u times. Patient neuroadaptation to multifocality occurred immediately post-Tx. Mean durations (SD) of functional (>20/40) binocular UNVA outcomes were 10.8 (9.1) m for primary Txs only and 15.2 (10.3)m for primary plus secondary Txs. CONCLUSIONS: In eyes with emmetropic presbyopia, optimal keratoplasty (Opti-K) is safe and efficacious for improving UNVA while retaining (or improving) UDVA. The procedure is noninvasive, simple, rapid, comfortable and repeatable. Although UNVA improvement is temporary, additional Opti-K Txs can be repeated whenever needed to maintain functional uncorrected near visual acuity.